Infantile and preschool asthma
| dc.contributor.author | Castro-Rodriguez, J.A. | |
| dc.contributor.author | Rodriguez-Martinez, C.E. | |
| dc.contributor.author | Custovic, A. | |
| dc.date.accessioned | 2023-05-19T20:49:56Z | |
| dc.date.available | 2023-05-19T20:49:56Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | In infants and preschool children the symptoms suggestive of asthma (e.g. wheeze) may be a clinical expression of a number of diseases with different aetiologies. If this is true, then it is unlikely that these different diseases would respond to the same treatment. Consequently, implementation of a management strategy which is effective for each individual patient is challenging, and controversies remain with respect to which patients should be given anti-asthma treatment, and when the treatment should be started and for how long. Whilst acknowledging these uncertainties, practicing physicians may use the Asthma Predictive Index (API) as a guide in clinical practice to identify young children with recurrent wheezing who are at risk of the subsequent development of persistent asthma, and who may benefit from preventative anti-asthma medication. We acknowledge that a number of questions on the most appropriate management strategy remain unanswered, including which type of medication is the best for individual patients (e.g. short-acting beta-agonist versus inhaled corticosteroid (ICS) versus leukotriene receptor antagonist (LTRA)), dose (high versus low) and schedule (regular versus as needed). | |
| dc.fuente.origen | ORCID-mayo23 | |
| dc.identifier.doi | 10.1183/1025448x.10000212 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/70102 | |
| dc.language.iso | en | |
| dc.rights | acceso restringido | |
| dc.title | Infantile and preschool asthma | es_ES |
| dc.type | libro |